spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Asthma 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 8 Apr 2024
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS(R) (edaravone)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 31 Jul 2023
Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 3 Nov 2022
Grifols Receives FDA Clearance for Alphaid(TM) At Home, the First Free Service for U.S. Consumers to Determine Their Risk for Alpha-1
Diagnostics FDA
 HSMN NewsFeed - 22 Aug 2022
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2022
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 13 May 2022
Medtronic completes acquisition of Intersect ENT
Devices Mergers & Acquisitions
 HSMN NewsFeed - 2 May 2022
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Apr 2022
Israeli startup Sanolla receives FDA clearance for the world's first AI-ready infrasound stethoscope
Devices FDA
 HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA
 HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2021
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 1 Jun 2021
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing
 HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jan 2021
Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jan 2021
Connect Biopharma Strengthens Leadership Team with Key Hire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Dec 2020
FDA Approves Bracco Diagnostics Inc.'s ProHance(R) (Gadoteridol) Injection, 279.3 mg/mL, for Pediatric Patients Younger than Two Years
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 22 Dec 2020
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
Biopharmaceuticals
 HSMN NewsFeed - 1 Dec 2020
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Nov 2020
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2020
CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 17 Aug 2020
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Biopharmaceuticals Drug Delivery Generics Distribution
 HSMN NewsFeed - 6 Aug 2020
FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 Jul 2020
FDA Clears First Blood Test for Identifying a Novel Allergic Sensitization to Red Meat
Diagnostics FDA
 HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 5 Jun 2020
Sosei Heptares Notes Phase IIIb ARGON Study With Enerzair(R) Breezhaler(R) (QVM149) Meets Primary Endpoint in Patients With Uncontrolled Asthma
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 May 2020
4DMedical's Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health
Diagnostics Radiology FDA
 HSMN NewsFeed - 18 May 2020
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 13 May 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2020
Hoth Therapeutics Announces Additions to its Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 15 Apr 2020
VIDA Completes Second Close Of Round C Financing
Devices Venture Capital
 HSMN NewsFeed - 18 Mar 2020
Pharmascience Inc. Launches pms-FLUTICASONE PROPIONATE/SALMETEROL DPI for the Maintenance Treatment of Asthma and COPD
Biopharmaceuticals Generics Drug Delivery Product Launch
 HSMN NewsFeed - 29 Jan 2020
Monoferric(R) (Ferric Derisomaltose) Injection Is Approved by the US FDA for the Treatment of Iron Deficiency Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jan 2020
Ninety Percent of Patients Can't Use Inhalers Correctly, Digital Inhaler CapMedic Receives FDA Clearance to Change That
Devices Drug Delivery FDA
 HSMN NewsFeed - 2 Jan 2020
Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson
Biopharmaceuticals Oncology Drug Delivery Licensing
 HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Oct 2019
VIDA Expands Board, Announcing Erkan Akyuz As Independent Director
Devices Radiology Oncology Personnel
 HSMN NewsFeed - 1 Oct 2019
Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS(R)
Biopharmaceuticals Generics Drug Delivery Distribution
 HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jun 2019
HemoShear Therapeutics Names Biopharma Veteran Kathleen M. Metters, PhD, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2019
Pulmatrix Announces Leadership Change
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 May 2019
Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Mar 2019
CHMP Recommends Approval of Dupixent(R) (dupilumab) for Asthma Indication
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Feb 2019
Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
Devices Venture Capital Personnel
 HSMN NewsFeed - 2 Jan 2019
Slayback Pharma Announces FDA Approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml in a Multi-Dose Vial, the First Generic Equivalent of Makena(R) Injection 1,250 mg/ 5 ml Multi-Dose Vial
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 23 Nov 2018
Indivior Announces Health Canada Approval of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Oct 2018
Pneuma Respiratory, Inc. Announces J. Knox Singleton Joins the Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2018
ANI Announces Launch of Authorized Generic of Brethine(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2018
Gala Presents Positive Results from First-In-Human Clinical Trial of RheOx(TM) in Chronic Bronchitis at the European Respiratory Society
Devices
 HSMN NewsFeed - 6 Sep 2018
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to product/label mix-up
Biopharmaceuticals FDA Product Recall
 HSMN NewsFeed - 31 Aug 2018
FDA announces voluntary recall of Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles
Biopharmaceuticals FDA Product Recall
 HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2018
Gala Therapeutics Receives FDA IDE Approval for a US Early Feasibility Study of Its RheOx(TM) System to Treat Chronic Bronchitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jun 2018
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
Biopharmaceuticals Generics
 HSMN NewsFeed - 11 Jun 2018
Propeller Health Raises Strategic Investment from McKesson Ventures
Devices Venture Capital
 HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Jun 2018
Henry Schein Medical Launches Its New EasyOne Air Spirometer
Devices Product Launch
 HSMN NewsFeed - 5 Jun 2018
Peer-Reviewed Study Demonstrates High Patient Satisfaction with Propeller Health's Digital Medicines for Asthma
Devices
 HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 16 May 2018
Positive Phase 3 Trial of DUPIXENT(R) (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 3 Apr 2018
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2018
Duchesnay USA Announces Launch of Bonjesta(R) (doxylamine succinate - pyridoxine hydrochloride) in the United States
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 27 Mar 2018
Convexity Scientific Receives FDA Clearance For Its FLYP(TM) Nebulizer, Unveils The New Device At Medtrade Spring
Devices FDA Product Launch
 HSMN NewsFeed - 2 Mar 2018
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2018
Blockchain Based Medical Device from NnBU Set to Raise €15million in ICO
Devices Venture Capital
 HSMN NewsFeed - 30 Jan 2018
Bracco Diagnostics Inc. receives U.S. Food and Drug Administration (FDA) approval for use of MultiHance(R) (gadobenate dimeglumine) injection in magnetic resonance imaging of the central nervous system in pediatric patients younger than two years of age
Biopharmaceuticals Devices Diagnostics Radiology FDA
 HSMN NewsFeed - 29 Jan 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jan 2018
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 12 Jan 2018
GSK receives FDA approval for expanded indication for FLUARIX(R) QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2017
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Diagnostics FDA Product Launch
 HSMN NewsFeed - 30 Nov 2017
Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA(R) (edaravone) to U.S. Department of Veterans Affairs National Formulary
Biopharmaceuticals Neurology Reimbursement
 HSMN NewsFeed - 20 Nov 2017
U.S. FDA Approves Kaléo's AUVI-Q(R) (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 13 Nov 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Nov 2017
EMD Serono Receives FDA Approval for New GONAL-f(R) RFF Redi-ject(R) Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Nov 2017
Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Sep 2017
Regeneron and Sanofi Announce Approval of DUPIXENT(R) (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 6 Sep 2017
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation
 HSMN NewsFeed - 27 Jul 2017
U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 25 Jul 2017
HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 20 Jul 2017
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2017
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
Devices
 HSMN NewsFeed - 11 May 2017
Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2017
Regeneron and Sanofi Announce Kevzara(R) (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Apr 2017
Inspirion Delivery Sciences Receives FDA Approval for RoxyBond(TM) (oxycodone hydrochloride) tablets CII, the First and Only Immediate Release Opioid Analgesic with Abuse-Deterrent Label Claims
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 25 Apr 2017
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 24 Apr 2017
Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara(R) (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Apr 2017
Monitored Therapeutics, Inc. Receives FDA Clearance for First Full Home-Use Spirometer With Wireless Connection
Devices FDA
 HSMN NewsFeed - 17 Apr 2017
AMAG Submits Supplemental New Drug Application to FDA for Makena(R) (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 17 Apr 2017
Xencor Appoints Kevin Gorman, Ph.D., to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2017
Foresee Pharmaceuticals Announces Completion of USD16M Fundraising
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Mar 2017
Sanofi and Regeneron Announce FDA Approval of Dupixent(R) (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 16 Mar 2017
Shire Receives European Approval for Label Extension of CINRYZE(R) (C1 inhibitor ) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Feb 2017
Kevzara(TM) (sarilumab) now available in Canada for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Feb 2017
FDA Expands Approval of SPIRIVA(R) RESPIMAT(R) (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Feb 2017
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 8 Feb 2017
GSK Consumer Healthcare Launches FLONASE(R) Sensimist(TM) Allergy Relief Nationwide
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 27 Jan 2017
Immune Pharmaceuticals Appoints New Chairman of the Board of Directors
Biopharmaceuticals Gastroenterology Oncology Personnel
 HSMN NewsFeed - 27 Jan 2017
Foresee Pharmaceuticals Announces Top-Line Results from Phase 3 Registration Study in Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jan 2017
Alkahest Appoints Sam Jackson, M.D., MBA as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2017
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 4 Jan 2017
Regeneron Hires Jay Markowitz, M.D., as Senior Vice President of Portfolio Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2016
Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent(R) (dupilumab) Accepted for Review by the EMA
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 17 Nov 2016
Regeneron and Sanofi Announce Praluent(R) (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2016
Propeller Health Receives FDA Clearance for the Propeller Platform in Association with GSK's Ellipta(R) Inhaler
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Oct 2016
Propeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy
Devices Venture Capital
 HSMN NewsFeed - 12 Oct 2016
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena(R) and Feraheme(R)
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Sep 2016
Insmed Appoints Roger Adsett as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2016
Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 12 Sep 2016
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2016
New Data: STIOLTO(R) RESPIMAT(R) (tiotropium bromide+olodaterol) Inhalation Spray Significantly Improved Exercise Capacity in People with COPD
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Aug 2016
Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent(R) (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2016
Mylan Taking Immediate Action to Further Enhance Access to EpiPen(R) (Epinephrine Injection, USP) Auto-Injector
Biopharmaceuticals Devices Drug Delivery Reimbursement
 HSMN NewsFeed - 12 Aug 2016
Flamel Technologies Launches Akovaz(TM)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 4 Aug 2016
Inspyr Therapeutics Appoints Christopher Lowe Chief Executive Officer and Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Aug 2016
FDA Approves FLONASE(R) Sensimist(TM) Allergy Relief
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jul 2016
Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP(TM) Allergy Testing Products
Diagnostics Product Launch
 HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 27 Jun 2016
Merck Receives CHMP Positive Opinion for KEYTRUDA(R) (pembrolizumab) for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Jun 2016
Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2016
Merck’s KEYTRUDA(R) (pembrolizumab) Demonstrates Superior Progression-Free and Overall Survival Compared to Chemotherapy as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Jun 2016
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
Biopharmaceuticals Generics Drug Delivery Product Launch
 HSMN NewsFeed - 23 May 2016
Egalet Settles Patent Litigations with Purdue Pharma
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 May 2016
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 18 Apr 2016
AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2016
Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 29 Mar 2016
Adamis Pharmaceuticals Announces Agreement to Acquire US Compounding
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Mar 2016
Tunitas Therapeutics Expands Management Team with Appointment of David J. King as Senior Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Mar 2016
Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2016
Galderma Delivers Innovation In Dermal Fillers With The Launch Of Two First-In-Class FDA Pivotal Phase III Trials
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 2 Feb 2016
Lupin Launches Generic Glumetza(R) HCI ER Tablets in the US
Biopharmaceuticals Generics Endocrinology Product Launch
 HSMN NewsFeed - 25 Jan 2016
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
Biopharmaceuticals Distribution Product Launch
 HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jan 2016
Monaghan Medical Introduces Manometer Adapter to Measure Treatment With Aerobika(R) OPEP Device
Devices Product Launch
 HSMN NewsFeed - 12 Jan 2016
Zambon Launches Xadago(R) (Safinamide) in Switzerland for Patients with Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 24 Dec 2015
Avita Medical Sells Respiratory Business for $2.64m
Devices Regenerative Medicine Acquisitions
 HSMN NewsFeed - 9 Nov 2015
OxySure (OXYS) Board Approves Name Change to OxySure Therapeutics, Inc.
Devices
 HSMN NewsFeed - 5 Nov 2015
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Sep 2015
Tunitas Therapeutics Closes $10 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 28 Sep 2015
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in the European Union
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 3 Sep 2015
Atopix Therapeutics Appoints Dr Andrew Zambanini as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2015
Xencor Appoints Yujiro S. Hata to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jul 2015
AnaptysBio Secures $40 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jul 2015
Boston Scientific Bronchial Thermoplasty Treatment Recognized By American College Of Allergy, Asthma And Immunology
Devices
 HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 May 2015
Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 15 May 2015
Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 1 Apr 2015
Teva Announces FDA Approval of ProAir(R) RespiClick
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Mar 2015
FDA Clearance for REZA BAND® UES Assist Device that Reduces Symptoms of Laryngopharyngeal Reflux (LPR)
Devices Gastroenterology FDA
 HSMN NewsFeed - 26 Feb 2015
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 24 Feb 2015
Shire Acquires Meritage Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Feb 2015
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
Devices Product Launch
 HSMN NewsFeed - 26 Jan 2015
Regeneron and Sanofi Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2014
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2014
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 10 Sep 2014
Airway Therapeutics Raises $4.6 Million in Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2014
Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizumab Treatment in Asthma Patients with Eosinophilia
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2014
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2014
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin
Biopharmaceuticals Endocrinology Drug Delivery Licensing
 HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 1 Aug 2014
FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jul 2014
RestorGenex Announces Management Changes
Biopharmaceuticals Dermatology Ophthalmology Personnel
 HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 13 Jun 2014
Ligand Partner GSK Announces Results of Phase 3 PETIT2 Study of Eltrombopag (Promacta(TM)/Revolade(TM)) in Pediatric Patients with Chronic Immune Thrombocytopenia
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2014
FDA approves Bayer's Gadavist (gadobutrol) Injection as the first magnetic resonance contrast agent for evaluation of breast cancer in the United States
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 12 Jun 2014
Aerocrine AB Announces Leadership Changes
Devices Personnel
 HSMN NewsFeed - 11 Jun 2014
GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2014
Masimo Announces CE Mark of iSpO2(TM) Rx Pulse Oximeter for Mobile Devices
Devices Monitoring Regulatory
 HSMN NewsFeed - 23 May 2014
Teva Received FDA Approval for QVAR(R) (beclomethasone dipropionate HFA) with Dose Counter
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2014
Teva Receives European Marketing Authorization for DuoResp Spiromax(R) for the Treatment of Asthma and COPD
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Apr 2014
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2014
OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device
Devices Regulatory
 HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
Devices FDA
 HSMN NewsFeed - 14 Mar 2014
GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2014
Teva Receives CHMP Positive Opinion for DuoResp(R) Spiromax(R) for the Treatment of Patients Diagnosed with Asthma and COPD in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 28 Jan 2014
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Devices FDA
 HSMN NewsFeed - 7 Jan 2014
Forma Therapeutics Appoints Christopher Dinsmore to Vice President, Medicinal and Computational Chemistry
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2014
Iroko’s ZORVOLEX(TM) Now Available
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 30 Dec 2013
Concordia Healthcare Corp. announces filing of Ulesfia(R) with Health Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Dec 2013
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 18 Dec 2013
Aerocrine Signs Distribution Deal with Intramedic for Sweden
Devices Diagnostics Distribution
 HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 2 Dec 2013
Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 22 Nov 2013
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2013
FDA Approves JUVÉDERM VOLUMA(TM) XC
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 16 Oct 2013
MediciNova Appoints Geoffrey O'Brien as Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2013
Immune Pharmaceuticals Announces Changes to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2013
FDA Files Genentech’s Supplemental Biologics License Application of Xolair(R) (omalizumab) for Chronic Idiopathic Urticaria (CIU)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Sep 2013
Aerocrine Launches a New Fully Portable Hand-Held Device to Measure Airway Inflammation in Asthma
Devices Product Launch
 HSMN NewsFeed - 30 Aug 2013
Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Aug 2013
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 7 Aug 2013
KaloBios Appoints V. Bryan Lawlis, Jr., Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2013
Edimer Secures $18M Series B Financing Led by New Enterprise Associates
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 17 May 2013
New Study Shows Effect of Neupro(R) (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2013
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA
 HSMN NewsFeed - 16 Apr 2013
Aerocrine’s NIOX MINO(R) device for measuring FeNO receives approval by Health Canada
Devices Regulatory
 HSMN NewsFeed - 4 Apr 2013
Aerocrine Passes Regulatory Milestone in Japan
Devices Regulatory
 HSMN NewsFeed - 3 Apr 2013
Aquinox Pharmaceuticals Completes US $18 million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
Biopharmaceuticals Generics Drug Delivery FDA
 HSMN NewsFeed - 18 Mar 2013
SinuSys Corp. Expands Executive Team
Devices Personnel
 HSMN NewsFeed - 28 Feb 2013
Pernix Therapeutics Receives FDA Approvals
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Feb 2013
Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection To Sandor Medicaids Pvt. Ltd. For Commercialization In India
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Jan 2013
FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jan 2013
Sanovas Files for FDA Clearance of Vas Zeppelin(TM) Smart Catheter(TM)
Devices Interventional FDA
 HSMN NewsFeed - 2 Jan 2013
FDA Grants Soligenix Orphan Drug Designation for OrbeShield(TM) for Treatment after Exposure to a Radiological Disaster
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 14 Nov 2012
Biota Pharmaceuticals Announces Appointment of New Executive Officers
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2012
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Nov 2012
Trinity Medical Center Adds Masimo Patient SafetyNet(TM) as a High Vigilance Safeguard for Post-Surgical Patients
Devices Monitoring
 HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Oct 2012
Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2012
Cytos Biotechnology Ltd appoints Dr. Christian Itin as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2012
Acton Pharmaceuticals Announces U.S. Food and Drug Administration Approval for AEROSPAN(R) (Flunisolide HFA, 80 mcg) Inhalation Aerosol for Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
Devices Interventional FDA Regulatory
 HSMN NewsFeed - 4 Sep 2012
Higher dose of Novartis drug Exelon(R) Patch approved by FDA for patients with mild to moderate Alzheimer's disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 20 Aug 2012
Reckitt Benckiser Pharmaceuticals Inc. Announces FDA Approval of Two New Dosage Strengths of Suboxone(R) Sublingual Film (C-III) for Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Aug 2012
Sanofi Announces FDA Approval for Auvi-Q(TM), First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 16 Jul 2012
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 13 Jul 2012
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Jul 2012
Asthmapolis Receives FDA Clearance for Asthma Inhaler Sensor Technology and Accompanying Software System
Devices FDA
 HSMN NewsFeed - 10 Jul 2012
Jeff Cooper Joins KaloBios as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Jun 2012
AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 18 May 2012
ApniCure Receives FDA 510(k) Clearance to Market Winx(TM) Sleep Therapy System for Treatment of Obstructive Sleep Apnea
Devices FDA
 HSMN NewsFeed - 16 May 2012
Armando Anido Joins Respira Therapeutics, Inc. Board of Directors
Devices Drug Delivery Personnel
 HSMN NewsFeed - 10 May 2012
SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to Budesonide Monotherapy in African-American Patients with Asthma
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2012
Aerocrine AB Announces New US Leadership
Devices Personnel
 HSMN NewsFeed - 16 Apr 2012
Array BioPharma Names Howard Holden, Ph.D., Vice President of Regulatory Affairs and Quality Assurance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 3 Apr 2012
Neupro(R) Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Apr 2012
Aerocrine: The ACAAI & AAAAI issue a joint position statement in support of the American Thoracic Society (ATS) Guidelines on FeNO
Devices
 HSMN NewsFeed - 23 Mar 2012
GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
Biopharmaceuticals
 HSMN NewsFeed - 21 Mar 2012
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2012
Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for Bronchial Thermoplasty
Devices Reimbursement
 HSMN NewsFeed - 10 Feb 2012
South Carolina Adopts Positive Coverage of Aerocrine’s FeNo Testing in Medicaid Program
Devices Reimbursement
 HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2012
Aerocrine appoints pulmonologist Paul Dorinsky, M.D., as medical director, North America
Devices Personnel
 HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2012
Boston Scientific's Alair(R) Bronchial Thermoplasty System Achieves Important Reimbursement Milestones
Devices Reimbursement
 HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 25 Oct 2011
Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Oct 2011
Panmira Announces Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Oct 2011
FDA Approves Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Sep 2011
Natus Acquires Embla Systems LLC - Leading Sleep Diagnostic Company
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Sep 2011
Aerocrine AB Announces the Appointment of Scott Myers to the Position of President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Aug 2011
Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2011
Pulmatrix Invests in Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2011
Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Aug 2011
Aerocrine Appoints Morten Gunvad as VP Commercial Operations Europe and Asia
Devices Personnel
 HSMN NewsFeed - 21 Jul 2011
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2011
Dennis M. Flannelly Joins Phadia as Head of U.S. Marketing and Strategy
Diagnostics Personnel
 HSMN NewsFeed - 29 Jun 2011
Pulmatrix Promotes Robert Clarke, PhD, to Chief Scientific Officer and Vice President of Research and Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 20 Jun 2011
Pulmatrix Launches iSPERSE(TM), A Novel Inhaled Dry Powder Drug Delivery Platform
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2011
Mylan to Rebrand Matrix Laboratories
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2011
Caldolor(R) Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
Biopharmaceuticals
 HSMN NewsFeed - 27 Apr 2011
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
Devices Monitoring
 HSMN NewsFeed - 25 Apr 2011
Horizon Pharma Announces FDA Approval of DUEXIS(R) (ibuprofen/famotidine) for the Relief of the Signs and Symptoms of Rheumatoid Arthritis and Osteoarthritis and to Decrease the Risk of Developing Upper Gastrointestinal Ulcers
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Apr 2011
Ligand Names Matthew W. Foehr Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2011
Antares Pharma Announces FDA Acceptance of Anturol(R) NDA for Filing
Biopharmaceuticals Urology
 HSMN NewsFeed - 29 Mar 2011
Aerocrine appoints Dr. Kathleen Rickard as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2011
FDA Expands Indication for ZOSTAVAX(R), Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Mar 2011
Data Presented at AAAAI Annual Meeting Further Support the Safety and Efficacy of FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Feb 2011
Cytokinetics Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2011
Newly Published Data Demonstrates Caldolor(R) Significantly Reduces Pain and Morphine Use in Post-Operative Patients
Biopharmaceuticals Pain Management Surgery
 HSMN NewsFeed - 26 Jan 2011
Ligand Acquires CyDex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jan 2011
U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra for Over-The-Counter Use
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jan 2011
Given Imaging's Bravo(R) pH Monitoring System Cleared for Use in Children
Devices Monitoring FDA
 HSMN NewsFeed - 22 Dec 2010
FDA Issues Complete Response Letter Regarding Acetadote(R) Supplemental New Drug Application for Acute Liver Failure
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Dec 2010
Pulmatrix Names Eva Jack as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Dec 2010
Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market
Devices FDA
 HSMN NewsFeed - 2 Dec 2010
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2010
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2010
Bronchial Thermoplasty Demonstrates Long-Term Asthma Control in Patients With Severe Asthma
Devices
 HSMN NewsFeed - 2 Nov 2010
Ligand Announces Approval for Revolade(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Nov 2010
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 26 Oct 2010
Boston Scientific Completes Acquisition of Asthmatx
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Oct 2010
FDA Approves Pharmaxis' ARIDOL (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 5 Oct 2010
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
Biopharmaceuticals Neurology Personnel FDA
 HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Sep 2010
AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Sep 2010
Deep Breeze Launches Unique, Non-Invasive, Radiation-Free Emergency Department Pulmonary Imaging System in the U.S.
Devices
 HSMN NewsFeed - 20 Sep 2010
Boston Scientific to Acquire Asthmatx
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2010
Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2010
Environmental Tectonics Corporation's Biomedical Systems Announces the Sale of a BARA-MED(R) Monoplace Hyperbaric Chamber for Placement in Vietnam
Devices Wound Care
 HSMN NewsFeed - 5 Aug 2010
Data from First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2010
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jul 2010
CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2010
Study Showed the Clinically Significant Therapeutic Benefit of Neupro(R) (rotigotine transdermal system) in the Treatment of Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 26 Jul 2010
FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jul 2010
Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA(R) Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2010
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Jun 2010
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jun 2010
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2010
Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Jun 2010
Rigel Pharmaceuticals Names Raul Rodriguez President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 May 2010
Aerocrine Acquires All Assets of U.S. Competitor and Ends Litigation
Devices Litigation
 HSMN NewsFeed - 11 May 2010
MAP Pharmaceuticals Provides Update on Progress of LEVADEX Development Program
Biopharmaceuticals
 HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Apr 2010
Asthmatx Receives FDA Approval for the Alair(R) Bronchial Thermoplasty System
Devices FDA
 HSMN NewsFeed - 26 Apr 2010
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
Biopharmaceuticals Distribution
 HSMN NewsFeed - 23 Apr 2010
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro(R) (Rotigotine)
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 13 Apr 2010
FDA Maintains Essential Use Status of Combivent(R) (ipratropium bromide and albuterol sulfate) Inhalation Aerosol Through 2013
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Apr 2010
New Data Show Sustained 5-Year Benefit of Neupro(R) (Rotigotine Transdermal System) for Symptoms of Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 7 Apr 2010
Idera Pharmaceuticals Announces Management Appointments and Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2010
Cephalon Completes Acquisition of Ception Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Mar 2010
Tomophase Corporation Names Ralph S. Johnston President and Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 22 Mar 2010
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2010
Environmental Tectonics Corporation Announces Additional Baramed Monoplace Hyperbaric Chamber Sales
Devices Wound Care
 HSMN NewsFeed - 20 Feb 2010
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2010
AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Feb 2010
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 10 Feb 2010
Boston Scientific Announces Management Changes and Restructuring Initiatives
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Feb 2010
Lupin Receives FDA Approval for Amlodipine/Benazepril Capsules
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 8 Feb 2010
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 28 Jan 2010
Lupin Receives U.S. FDA Approval For Perindopril Erbumine Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jan 2010
Phadia Brings the First and Only Point of Care In Vitro Specific IgE Allergy Test into the Physician's Office with Final FDA Clearance of the ImmunoCAP(R) Rapid System
Diagnostics FDA
 HSMN NewsFeed - 21 Jan 2010
Lupin Receives US FDA Tentative Approval for Memantine HCl Tablets
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 18 Jan 2010
Covidien and Allergan Extend Agreement to Promote LAP-BAND(R) Adjustable Gastric Banding System
Devices Surgery Distribution
 HSMN NewsFeed - 11 Jan 2010
MAP Pharmaceuticals Announces FDA will not Require a Second Pivotal Efficacy Study for LEVADEX(TM) NDA Submission
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 7 Jan 2010
Forest and Almirall Announce Positive Results from the ACCORD COPD I Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Dec 2009
Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Dec 2009
Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2009
La Jolla Pharmaceutical Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2009
MicroDose Therapeutx Acquires Epix Pharmaceuticals Portfolio of Compounds for Treatment of Chronic Constipation and Irritable Bowel Syndrome with Constipation (IBS-C)
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 30 Nov 2009
sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America
Devices Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 27 Nov 2009
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Nov 2009
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Nov 2009
Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 Nov 2009
Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2009
Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency
Biopharmaceuticals
 HSMN NewsFeed - 11 Nov 2009
Altair Therapeutics Secures $17 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2009
Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Biopharmaceuticals
 HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Oct 2009
Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2009
Arginetix Closes $10.75 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Sep 2009
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2009
Aerocrine: Canada Approves NIOX MINO for Asthma Monitoring
Devices Monitoring Regulatory
 HSMN NewsFeed - 3 Sep 2009
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Aug 2009
Eurand Granted FDA Approval for ZENPEP(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Aug 2009
FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Aug 2009
Merck Wins SINGULAIR(R) Patent Infringement Lawsuit
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Aug 2009
David Esposito Joins Phadia as Senior Vice President of U.S. Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 4 Aug 2009
DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2009
Sciele Pharma and Plethora Solutions Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
Biopharmaceuticals
 HSMN NewsFeed - 27 Jul 2009
Custom Spine Announces New Board of Directors and CFO
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 27 Jul 2009
Halozyme Therapeutics Appoints Jonathan Leff, M.D. as Vice President, Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2009
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jul 2009
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2009
Huntington Memorial Hospital is First in Southern California to Install Toshiba's Aquilion ONE Dynamic Volume CT System
Devices Radiology
 HSMN NewsFeed - 29 Jun 2009
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Devices Surgery
 HSMN NewsFeed - 17 Jun 2009
Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jun 2009
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2009
Medical Acoustics Files Application with FDA for 510(k) Clearance of Therapeutic Lung Flute
Devices
 HSMN NewsFeed - 1 Jun 2009
Study Confirms Given Imaging's Bravo(R) pH Monitoring System to Be a Very Effective Diagnostic Tool for Assessing GERD
Devices Monitoring Gastroenterology
 HSMN NewsFeed - 29 May 2009
Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 May 2009
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2009
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 May 2009
Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2009
Altair Therapeutics Appoints Dr. Joel Martin President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2009
New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children
Devices Monitoring
 HSMN NewsFeed - 8 May 2009
New Data Shows Blood Pressure Reduction Therapy With BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2009
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2009
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 27 Apr 2009
Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Apr 2009
Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2009
MediciNova Reports Final Data from Phase II MN-221 Emergency Department Clinical Trial (MN-221-CL-006); Hospitalization Rates Decrease 45 Percent With MN-221 Plus Standardized Care in Asthma Patients
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2009
Aerovance Secures $38 Million in Equity Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 24 Mar 2009
FABLYN Approved in Europe for the Treatment of Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Mar 2009
Skyepharma PLC Announces Regulatory Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2009
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2009
Merck and Schering-Plough to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Mar 2009
Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Feb 2009
Aton Pharma Acquires U.S. TIMOPTIC(R)
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 23 Feb 2009
MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2009
Aerovance Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2009
FDA Advisory Committee Favors Approval of DX-88 for Acute Attacks of Hereditary Angioedema
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 26 Jan 2009
Nonin Medical, Inc. Makes History With the First Continua(TM) Certified Product
Devices Monitoring
 HSMN NewsFeed - 22 Jan 2009
Axikin Pharmaceuticals Spins out of Actimis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jan 2009
Lupin is Granted USFDA Approval for Levetiracetam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Jan 2009
Cephalon Signs Option Agreement to Acquire Ception Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 13 Jan 2009
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2009
TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients
Biopharmaceuticals
 HSMN NewsFeed - 6 Jan 2009
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
Biopharmaceuticals
 HSMN NewsFeed - 23 Dec 2008
MediciNova Proposes to Acquire Avigen, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Dec 2008
Amgen Submits Biologics License Application for FDA Approval of Denosumab in Women With Postmenopausal Osteoporosis and in Patients Undergoing Hormone Ablation for Either Prostate or Breast Cancer
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2008
GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2008
Given Imaging Acquires Medtronic's Bravo(R) pH Monitoring Business for Diagnosing GERD
Devices Gastroenterology Acquisitions
 HSMN NewsFeed - 8 Oct 2008
Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 3 Oct 2008
Deep Breeze Announces Latest Study Results on Vibration Response Imaging (VRI(TM)) at the 18th European Respiratory Society Congress
Devices
 HSMN NewsFeed - 24 Sep 2008
New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
Devices Surgery
 HSMN NewsFeed - 24 Sep 2008
ZaBeCor Pharmaceuticals Announces Formation of Biothorpe Pharmaceuticals
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Sep 2008
KaloBios Raises $20 Million in Series D Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Sep 2008
Oriel Therapeutics Appoints Richard Fuller as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2008
FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Sep 2008
Portability of Sleep Apnea Treatment Devices Provides Uninterrupted Rest Without the Hassle
Devices
 HSMN NewsFeed - 19 Sep 2008
Shionogi and Sciele Announce Receipt of United States Antitrust Clearance
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2008
DOR BioPharma Forms orBec(R) European Medical Advisory Board
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2008
Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2008
Ban of CFC in Inhalers Spurs Product Innovation, Market Growth
Devices Drug Delivery
 HSMN NewsFeed - 8 Sep 2008
MediciNova to Present At Merriman Curhan Ford's 5th Annual Investor Summit 2008
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2008
MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 2 Sep 2008
Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 19 Aug 2008
Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2008
Inhaler Devices are Still a Major Hurdle in Asthma and COPD Treatment
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 25 Jul 2008
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
Biopharmaceuticals
 HSMN NewsFeed - 23 Jul 2008
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2008
Genaera Corporation Elects Paul K. Wotton to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 24 Jun 2008
Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 16 Jun 2008
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2008
Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Diagnostics Cardiology
 HSMN NewsFeed - 30 May 2008
Lupin Receives USFDA Approval for Topiramate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 May 2008
Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (FOSAMAX(R))
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2008
CDC Recommends ZOSTAVAX(R), Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
New Data Shows 45 Percent of Patients With Stage 1 Hypertension Reached Normotension With BENICAR(R) and BENICAR HCT(R)
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Asthma
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.